Profile
Anders Lilja worked as a Director of Virology & Molecular Biology at Batavia Biosciences BV from 2013 to 2014.
He then worked as a Senior Vice President of Technical Development at HOOKIPA Pharma, Inc. from 2014 to 2021.
Lilja holds a doctorate degree from the University of Maryland and an undergraduate degree from Chalmers University of Technology.
Former positions of Anders Lilja
| Companies | Position | End |
|---|---|---|
| HOOKIPA PHARMA INC. | Chief Tech/Sci/R&D Officer | - |
Batavia Biosciences BV
 Batavia Biosciences BV Pharmaceuticals: MajorHealth Technology Batavia Biosciences BV provides biopharmaceutical process development services. It offers biopharmaceutical materials research and pre-clinical study services for biopharmaceutical clients. The firm services cover candidate selection, production of research materials, upstream and downstream process development, assay development, product characterization and clinical manufacturing and release. The company was founded in 2010 and is headquartered in Leiden, the Netherlands. | Corporate Officer/Principal | 2013-12-31 |
Training of Anders Lilja
| University of Maryland | Doctorate Degree |
| Chalmers University of Technology | Undergraduate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Listed companies | 1 |
|---|---|
| HOOKIPA PHARMA INC. | Health Technology |
| Private companies | 1 |
|---|---|
Batavia Biosciences BV
Batavia Biosciences BV Pharmaceuticals: MajorHealth Technology Batavia Biosciences BV provides biopharmaceutical process development services. It offers biopharmaceutical materials research and pre-clinical study services for biopharmaceutical clients. The firm services cover candidate selection, production of research materials, upstream and downstream process development, assay development, product characterization and clinical manufacturing and release. The company was founded in 2010 and is headquartered in Leiden, the Netherlands. | Health Technology |
- Stock Market
- Insiders
- Anders Lilja
